Aurobindo Pharma surpasses Dr Reddy's in FY26 revenue, becoming the second-largest Indian pharma company.
SENSEX 75,495.00
+ 311.64
NIFTY 23,752.85
+ 98.15
CRUDEOIL 9,403.00
During January-March, the company's revenue from operations increased to ₹30,813 crore from ₹29,316 crore recorded in the fourth…
Q4 Results Today, 18th May 2026: Find all the latest Q4 results 2026 updates of 63 Moons Technologies, Afcons Infrastructure,…
Indian equity markets show a mixed but improving consumption trend, with selective FMCG and premium retail outperforming. Page…
Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US…
Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The…
Airtel’s total market cap stood at ₹11,80,328 crore, narrowly edging past HDFC Bank’s ₹11,82,223 crore — a gap that fluctuated…
